Ann: Company Presentation - Path to Commercial Revenue, page-5

First 5 Last

Share
Profile

Follow
Bullrush007

5,800 Posts.

706

02/03/20

20:05

Post #: 43266220
Share

Originally posted by awg801: ↑

I could be wrong but I believe this is the first time BLG have published forecast earnings. Previously, discussions with analysts have led them to forecast potential earnings, not BLG.

This preso is clever (tricky) in publishing lines on a graph vs actual numbers. Very hard to pull the revenue number for 2020 & 2021 from that graph, but, then again, that is not the point. They are providing a high level view of what they conservatively think is possible and the revenue trend is definitely up.

We all know BLG will need to raise some funds, but it is important to note, it will probably only be for operational expenses + some capital for setting up the laser diode test facility. The outsourced packaging work is an opex expense. I would expect the results of laser diode prototype development will be announced to support their financing endeavours. It may be a mix of debt and capital raising (sophs + SPP).

BLG has control of laser diode development. BLG has less control over the other development pipelines, and these could bear (financial) fruit at anytime.

The question is - Does history repeat? If it does, have a look at the 5yr chart. That may be a guide of what could happen. Note - You can see the impact of two capital raisings. The second was for the facility upgrade and scaling, which is still in progress (i.e. G4 conversion to RPCVD).

Expand

The big unknown is the Tech and Market Risk on page 13 of the presentation

How much of that forecast revenue will be impacted by this coronavirus?!

The G4 commissioning seems to have already been impacted

Long way to go!

BLG Price at posting: 5.7¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

OJC

SPC to merge with Original Juice Co and Nature One Dairy

There are more pages in this discussion • 5 more messages in this thread...

First 5 Last

Add BLG (ASX) to my watchlist

(20min delay)
Last 2.5¢		Change 0.000(0.00%)		Mkt cap ! $45.97M

Open	High	Low	Value	Volume
2.6¢	2.6¢	2.4¢	$77.28K	3.043M

Buyers (Bids)

No.	Vol.	Price($)
4	304438	2.4¢

Sellers (Offers)

Price($)	Vol.	No.
2.6¢	535000	2

View Market Depth

No.	Vol.	Price($)
4	304438	0.024
13	1347358	0.023
16	991822	0.022
5	384476	0.021
12	504906	0.020

Price($)	Vol.	No.
0.026	535000	2
0.027	140000	1
0.028	220000	1
0.029	468000	3
0.030	1115738	6

Last trade - 16.10pm 02/10/2024 (20 minute delay)

BLG (ASX) Chart

Ann: Company Presentation - Path to Commercial Revenue, page-5

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Company Presentation - Path to Commercial Revenue, page-5

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

SPC to merge with Original Juice Co and Nature One Dairy

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News